Cmbio
Rasmus Vendler Toft-Kehler is a seasoned entrepreneur and board member with extensive experience in various industries. As a co-founder and board member of UNION therapeutics A/S, Clinical-Microbiomics A/S, and UTILITY therapeutics since 2011, 2015, and 2017 respectively, Rasmus has significantly contributed to advancements in therapeutic solutions. Prior to these roles, Rasmus served as an originator and captain on a Pacific Ocean crossing and worked as a senior consultant at Booz Allen Hamilton, as well as a financial analyst at Goldman Sachs. Rasmus's career began at Multi-Tool A/S, a family business in which Rasmus held the position of executive assistant and board member until its acquisition by FEIN GmbH in 2005. Educational qualifications include an executive education at Harvard Business School and a Ph.D. in serial entrepreneurship from CBS and New York University, alongside a bachelor's degree in business administration and finance.
This person is not in the org chart
This person is not in any teams
Cmbio
Cmbio®, is at the forefront of the human, animal, and planetary health—microbiome science. Formed from the unification of industry leaders like Clinical Microbiomics, CosmosID, MS-Omics, DNASense and Microba’s Research Services, Cmbio® stands as the first global microbiome service and technology company equipped with state-of-the-art multi-omics laboratories and advanced bioinformatics. Our mission is to demystify the complex interplay of the microbiome and its vast influence on health and disease. By integrating applied AI with integrative systems biology, Cmbio® offers unparalleled insights and enterprise solutions that accelerate the pace of discovery and innovation in microbiome research. With GxP-compliant facilities and a robust, scalable software platform, Cmbio® is uniquely positioned to standardize microbiome analysis, ensuring reliability and comparability across global studies. We are committed to advancing scientific understanding and enhancing well-being across all life on our planet. Connect with Cmbio®: Explore how we're making strides in microbiome research and offering cutting-edge solutions to meet the grand challenges of health and sustainability.